Literature DB >> 16309187

Unfiltered xenon light is useful for photodynamic therapy with acridine orange.

Hideki Ueda1, Hiroaki Murata, Hideyuki Takeshita, Ginjiro Minami, Shin Hashiguchi, Toshikazu Kubo.   

Abstract

We have clarified that photodynamic therapy (PDT) with acridine orange (AO) exerts a rapid and strong cytocidal effect on mouse osteosarcomas, both in vitro and in vivo, and have sought to apply this therapy to patients with musculoskeletal sarcomas, in order to reduce the surgical margin and obtain better limb function after tumor resection in limb salvage surgery. Some clinical studies have reported that the local recurrence rate after limb salvage surgery in patients receiving PDT therapy was less than 10% and that the limb functions recovered to nearly normal in these patients. For these basic and clinical studies, we used a blue light beam filtered from a xenon lamp for the AO excitation, because of its maximal absorption. However, the relationship between the cytocidal effect of PDT and the wavelength or illuminance (lux) of the excitation light in AO-PDT is unknown. Therefore, we investigated the cytocidal effects of AO-PDT on mouse osteosarcoma cells using lights of various illuminances and wavelengths from a xenon lamp. Our results revealed that, while the blue and green filtered lights exerted cytocidal effects depending on their illuminance, orange light exerted no such effect. Blue light showed the strongest cytocidal effect under constant illuminance. However, unfiltered light with 10 times the illuminance of blue light yielded a much stronger cytocidal effect, which was deduced not to be due to DNA injury by ultra-violet light or heat generation by ultra-red light, since a xenon lamp emits little of either light. Based on these results, we conclude that, for effective AO-PDT in clinical practice, strong unfiltered light from a xenon lamp is more effective and feasible than weak filtered blue light.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16309187

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  In vivo anti-tumor activity of photodynamic therapy with intravenous administration of acridine orange, followed by illumination with high-power flash wave light in a mouse osteosarcoma model.

Authors:  Haruhiko Satonaka; Katsuyuki Kusuzaki; Takao Matsubara; Ken Shintani; Tomoki Nakamura; Akihiko Matsumine; Takahiro Iino; Atsumasa Uchida
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

2.  Intraoperative acridine orange photodynamic therapy and cribriform electron-beam irradiation for canine intranasal tumors: A pilot study.

Authors:  Takuya Maruo; Koichi Nagata; Yasuhiro Fukuyama; Yuki Nemoto; Shinpei Kawarai; Yukihiro Fujita; Tomohiro Nakayama
Journal:  Can Vet J       Date:  2015-12       Impact factor: 1.008

Review 3.  Progress of Phototherapy Applications in the Treatment of Bone Cancer.

Authors:  Jiachen Sun; Fei Xing; Joy Braun; Frank Traub; Pol Maria Rommens; Zhou Xiang; Ulrike Ritz
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

4.  Progress of photodynamic therapy applications in the treatment of musculoskeletal sarcoma (Review).

Authors:  Xianghong Zhang; Tang Liu; Zhihong Li; Xiangsheng Zhang
Journal:  Oncol Lett       Date:  2014-07-09       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.